Source 1primary paper2025MED
Toolkit/silkworm-baculovirus expression vector system
silkworm-baculovirus expression vector system
Also known as: silkworm-baculovirus system
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
VP1 from four epidemiologically relevant GI genotypes was expressed using the silkworm-baculovirus system.
Usefulness & Problems
No literature-backed usefulness or problem-fit explainer has been materialized for this record yet.
Published Workflows
Objective: Produce and characterize GI norovirus VP1-derived VLPs from four epidemiologically relevant genotypes, define genotype-specific purification and stability constraints, and generate data relevant to multivalent vaccine design.
Why it works: The workflow combines expression and genotype-specific purification with orthogonal structural, size-distribution, thermal-stability, and functional-binding assays to define whether GI VP1 forms VLPs that remain structurally intact and epitope competent under different conditions.
VLP assembly from VP1retention of HBGA-binding functional epitopesgenotype-dependent structural stabilitysilkworm-baculovirus expressiongenotype-specific purification optimizationSECDLSTEMDSFHBGA-mimic binding assay
Stages
- 1.Expression of GI VP1 constructs in silkworm-baculovirus system(library_build)
This stage creates the genotype-specific VP1 particle material needed for purification and all downstream analyses.
Selection: Generate VP1-derived material from four epidemiologically relevant GI genotypes for downstream purification and characterization.
- 2.Genotype-specific purification optimization(secondary_characterization)
Purification is needed before structural, stability, and functional analyses, and the abstract states that conditions differed by genotype.
Selection: Optimize purification conditions in a genotype-specific manner.
- 3.Orthogonal structural and biophysical characterization(functional_characterization)
This stage establishes structural and biophysical profiles of the purified GI VLPs.
Selection: Analyze purified VLPs using SEC, DLS, TEM, and DSF.
- 4.Functional epitope confirmation by HBGA-mimic binding(confirmatory_validation)
After structural characterization, the study confirms that purified particles still present functional epitopes.
Selection: Confirm functional epitopes via binding to HBGA mimics.
- 5.Stability assessment across pH and temperature conditions(secondary_characterization)
This stage identifies genotype-specific stability constraints that directly inform design and formulation of multivalent vaccines.
Selection: Assess genotype-dependent pH and thermal tolerance including aggregation and structural transitions.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A delivery strategy grouped with the mechanism branch because it determines how a system is instantiated and deployed in context.
Target processes
No target processes tagged yet.
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
The study defines genotype-specific purification, structural characterization, and stability profiles for four GI norovirus VLPs and provides a systematic framework relevant to multivalent vaccine design.
The purified GI norovirus VLPs retained functional epitopes as confirmed by binding to HBGA mimics.
VP1 from four epidemiologically relevant GI norovirus genotypes was expressed in the silkworm-baculovirus system and yielded purified VLPs that were structurally and biophysically characterized.
The GI norovirus VLPs showed genotype-dependent differences in pH and thermal tolerance, including aggregation and structural transitions.
Approval Evidence
1 source2 linked approval claimsfirst-pass slug silkworm-baculovirus-expression-vector-system
VP1 from four epidemiologically relevant GI genotypes was expressed using the silkworm-baculovirus system.
Source:
framework contributionsupports
The study defines genotype-specific purification, structural characterization, and stability profiles for four GI norovirus VLPs and provides a systematic framework relevant to multivalent vaccine design.
Source:
production and characterizationsupports
VP1 from four epidemiologically relevant GI norovirus genotypes was expressed in the silkworm-baculovirus system and yielded purified VLPs that were structurally and biophysically characterized.
Source:
Comparisons
No literature-backed comparison notes have been materialized for this record yet.
Ranked Citations
- 1.